Which of the following medical conditions are responsible for producing incorrect Alpha-fetoprotein (AFP) screening results and indicating a fetus has genetic defects?

The correct option is "The mother has Rh-negative blood".

Alpha-fetoprotein (AFP) is a glycoprotein produced during fetal development, primarily by the yolk sac and the fetal liver. It is a major serum protein in the developing fetus. Measuring the maternal serum AFP (MSAFP) levels is a routine screening test performed during pregnancy, typically between the 15th and 20th weeks of gestation, to assess the risk of certain congenital conditions (such as neural tube defects like spina bifida, and chromosomal abnormalities like Down syndrome).

Maternal-fetal blood group incompatibility, specifically when the mother has Rh-negative blood and is carrying an Rh-positive fetus, can lead to maternal sensitization and fetal erythroblastosis (Rh disease). In such immunological responses, the disruption of the placental barrier or increased permeability can cause an abnormal transfer of fetal proteins, including AFP, into the maternal circulation. This elevates the maternal serum AFP levels abnormally, leading to incorrect screening results that may falsely suggest the presence of genetic or structural defects in the fetus.